Patrizia AG (PAT)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 6.350 |
|---|---|
| 52-week range | 6.110 – 8.900 |
| Return, 1 month / 3 months | −8.4% / −11.6% |
| Return, 1 year / 3 years | −14.3% / +1.5% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 28.8% |
| Worst drawdown (1 year) | -25.5% |
| Average daily value traded | 0.42M EUR |
| Dividend yield | 5.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Patrizia is a real estate investment company based in Augsburg, Germany. It manages property portfolios and investment funds on behalf of institutional investors and private clients, and it also provides asset management and property services. Its activities cover residential and commercial real estate across several European markets, where it acquires, manages and develops buildings for its investors. The company earns fees for managing these assets and for related services rather than from selling goods to consumers.
The shares are listed on the XETRA Stock Exchange in Germany under the code PAT, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Patrizia AG (PAT) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 6.350 on 23 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 385 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.3% and over the last three months it fell 11.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 34 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.7% | ||
| From 52-week high | -28.3% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -11.6% | ||
| 6-month return | -9.4% | ||
| 12-month return, skipping the last month | -6.5% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.5% | ||
| Liquidity | 63 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.42M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.7% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.5% |
|---|---|
| 1 month | −8.4% |
| 3 months | −11.6% |
| 6 months | −9.4% |
| 1 year | −14.3% |
| 3 years | +1.5% |
| 5 years | −66.1% |
Signals
| 50-day / 200-day average | 6.929 / 7.277 |
|---|---|
| Golden / death cross (60 days) | Death, 29 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.184 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 Jun 2026 | EUR 0.3600 |
| 5 Jun 2025 | EUR 0.3500 |
| 13 Jun 2024 | EUR 0.3400 |
| 26 May 2023 | EUR 0.3300 |
| 2 Jun 2022 | EUR 0.3200 |
| 15 Oct 2021 | EUR 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.